With personnel based in Utah and in Massachusetts, the bioinformatics company Frameshift Genomics is currently structured to commercialize Lobio, a computational platform developed by researchers at the University of Utah offering tools for visualizing and analyzing genomic data. The effort is make genomic analysis more accessible to clinicians who want to use bioinformatics tools but lack the relevant expertise to do so. The platform marries data visualization with real-time analysis to help researchers ask more questions andto follow up their hypotheses, Specifically focused to development of an app for data quality control and quality assurance, the planned app is called Multibam.iobio and will help users quickly analyze Bam files and will provide several metrics that highlight particular data quality issues and how these can be corrected. suspected to have some connection to the disorder in question. The premium version of Gene.iobio is designd to allows simultaneous analysis of a user's entire gene list. The Iobio platform was developed a few years ago in the laboratory of Gabor Marth, a professor of human genetics at the University of Utah. It offers access to apps such as Bam.iobio, which was described in an article in Nature Methods, as well as to the open-source version of the soon- to-be-commercialized Gene.iobio. Also available is Taxonomer.iobio, which offers metagenomics classification and analysis tools, and Vcf.iobio a tool for sampling VCF files and generating metrics about them, such as variant density, base changes, and allele frequencies.
